As more Medicare beneficiaries turn to cannabis, rates of health care encounters involving cannabis-related disorders have increased. A recent study by the Food and Drug Administration (FDA) analyzed data from nearly 56 million Medicare beneficiaries aged 65 and older. The findings reveal a concerning trend in cannabis use among older Americans, with implications for health care and policy.
Subheading 1: Rising Rates of Cannabis-Related Disorders
From 2017 through 2022, health care encounters related to cannabis disorders rose among Medicare beneficiaries. These encounters included various cannabis-related issues, from abuse with withdrawal to dependence with intoxication delirium. The increase occurred regardless of a state or territory’s cannabis laws.
Subheading 2: Legalization and Health Care Encounters
Rates of cannabis-related disorder encounters were highest in locations where cannabis is legal for both medical and adult recreational use. Researchers observed the greatest increases in nonemergency outpatient settings. Beneficiaries enrolled in Medicare Advantage plans experienced higher average annual increases in cannabis-related disorder encounters compared to fee-for-service enrollees.
Subheading 3: Ensuring Safe Cannabis Use Among Older Adults
Strengthening the connection between cannabis and health care is crucial. Open, nonjudgmental conversations between clinicians and patients can help ensure safe cannabis consumption. As awareness grows, older adults need accurate information to make informed decisions about cannabis use.
